CLINICAL_TRIALS
trial_result
· 2022-02-02
Clinical Trial Update: A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma [Phase 4]
Summary
Phase 4 trial update investigating probiotics as an adjunct to immunotherapy for bladder urothelial carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tianjin Medical University Second Hospital | Conditions: Bladder Urothelial Carcinoma | Phase 4 | Status: UNKNOWN